About Synthace
Synthace is a company based in London (United Kingdom) founded in 2011 by Markus Christian Gershater. Synthace has raised $80.27 million across 8 funding rounds from investors including Horizons Ventures, Sofinnova Partners and SOSV. The company has 68 employees as of December 31, 2020. Synthace offers products and services including Synthace Software, DOE Training Course, and Dilution Calculator. Synthace operates in a competitive market with competitors including Waters Corporation, Tecan, Emerald Therapeutics, Quartzy and CrelioHealth, among others.
- Headquarter London, United Kingdom
- Employees 68 as on 31 Dec, 2020
- Founders Markus Christian Gershater
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Synthace Limited
- Date of Incorporation 31 May, 2011
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
$2.41 M (USD)47as on Jan 31, 2023
-
Net Profit
-$11.58 M (USD)-7as on Jan 31, 2023
-
EBITDA
-$13.47 M (USD)-5as on Jan 31, 2023
-
Total Equity Funding
$80.27 M (USD)
in 8 rounds
-
Latest Funding Round
$35 M (USD), Series C
Nov 16, 2021
-
Investors
Horizons Ventures
& 8 more
-
Employee Count
68
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synthace
Synthace offers a comprehensive portfolio of products and services, including Synthace Software, DOE Training Course, and Dilution Calculator.
Software for automating and optimizing biological experiments.
Training on Design of Experiments for scientific research.
Online tool for accurate dilution calculations in labs.
People of Synthace
Unlock access to complete
Unlock access to complete
Funding Insights of Synthace
Synthace has successfully raised a total of $80.27M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $35 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Synthace
Synthace has secured backing from 9 investors, including venture fund investors. Prominent investors backing the company include Horizons Ventures, Sofinnova Partners and SOSV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Horizons Ventures is focused on investing in deep science and technology.
|
Locked | Locked | Locked | |
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Locked | Locked | Locked | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Locked | Locked | Locked |
Investor details for Synthace
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synthace
Investment portfolio details for Synthace
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Synthace
Detailed financials for Synthace
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synthace Comparisons
Peer comparison for Synthace
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Synthace
Synthace operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Waters Corporation, Tecan, Emerald Therapeutics, Quartzy and CrelioHealth, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of laboratory management system for researchers and clinicians
|
|
| Locked | Locked | Locked |
Automated laboratory instruments, robotics, and diagnostic solutions are provided.
|
|
| Locked | Locked | Locked |
Cloud-based remote lab automation software is offered for life sciences.
|
|
| Locked | Locked | Locked |
Lab management platform for life sciences is offered by Quartzy.
|
|
| Locked | Locked | Locked |
SaaS-based laboratory information system is provided for clinicians.
|
Detailed competitors of Synthace
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synthace
Complete news archive for Synthace
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synthace
Synthace was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Synthace is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Markus Christian Gershater is the current CEO of Synthace. They have also founded this company.
Synthace is a funded company, having raised a total of $80.27M across 8 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Synthace is 68.
Annual revenue of Synthace is $2.41M as on Jan 31, 2023.
Synthace was founded in 2011 in London, United Kingdom, within the biotechnology sector. SaaS-based software for laboratory automation is offered to researchers, enabling experiment automation through products like Antha. An interoperable system is included for error detection and can be reprogrammed to manage liquid handling in biological experiments. Operations focus on streamlining research workflows across global labs.
Synthace's top competitors include Tecan, Waters Corporation and Automata.
Synthace offers Synthace Software, DOE Training Course, and Dilution Calculator.
Synthace has 9 investors. Key investors include Horizons Ventures, Sofinnova Partners, SOSV, Luminous Ventures, and Amadeus Capital Partners.
The valuation of Synthace is $71.3M as of Dec 2018.